N Engl J Med 1999; 341: 410- 418.
(Helsinki Heart Study: primary prevention with gemfibrozil in middle aged men with dyslipidemia, N Engl J Med 1987; 317: 1237- 1245.) A VA- HIT tanulmány eredményeit Rubins HB, Robins SJ, Collins D et al. tette közzé (Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high- density lipoprotein cholesterol, N Engl J Med 1999; 341: 410- 418.)